GALNT2 and breast carcinoma: The gene-coding GalNAc-transferase (GALNT2-SRD5A3) that binds glycosyl residues to glycoproteins belongs to a family of genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer [45].